TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 12013059

Group type: EXPERIMENTAL
Intervention: Physical abuse with parental marital disruption
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: Physical abuse without parental marital disruption
Number of subjects: 198

Group type: COMPARATOR
Intervention: Parental marital disruption without physical abuse
Number of subjects: 198

Group type: COMPARATOR
Intervention: Non-abused adolescents with parental marital disruption
Number of subjects: 198
Study: 10211260

Group type: EXPERIMENTAL
Intervention: Problem-Based Learning (PBL)
Number of subjects: 123

Group type: COMPARATOR
Intervention: Lecture-Based Learning (LBL)
Number of subjects: 123
Study: 7881965

Group type: EXPERIMENTAL
Intervention: Immediate modified radical mastectomy
Number of subjects: 79

Group type: COMPARATOR
Intervention: Initial cytotoxic or endocrine treatment followed by mastectomy
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Both groups (Immediate modified radical mastectomy and Initial cytotoxic or endocrine treatment)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Primary systemic therapy
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Obesity
Number of subjects: 79
Study: 2229749

Group type: COMPARATOR
Intervention: Medical therapy
Number of subjects: 42

Group type: COMPARATOR
Intervention: Surgical therapy
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Grafted segments
Number of subjects: 42

Group type: COMPARATOR
Intervention: Nongrafted segments
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Grafted arteries
Number of subjects: 42

Group type: COMPARATOR
Intervention: Nongrafted arteries
Number of subjects: 42

Group type: COMPARATOR
Intervention: Medically treated patients
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Proximal segments in grafted vessels
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Distal segments in grafted vessels
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Segments with occluded grafts
Number of subjects: 42

Group type: COMPARATOR
Intervention: Segments with patent grafts
Number of subjects: 42
Study: 353121

Group type: EXPERIMENTAL
Intervention: Cyclandelate 1600 mg daily
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study: 7137535

Group type: EXPERIMENTAL
Intervention: KWD 2131
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Terbutaline
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: KWD 2131 and Terbutaline
Number of subjects: 12
Study: 30614616

Group type: EXPERIMENTAL
Intervention: Ertugliflozin 5 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ertugliflozin 15 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo/Glimepiride
Number of subjects: 0
Study: 29474935

Group type: EXPERIMENTAL
Intervention: Turbuhaler® M3 (1.5 mg terbutaline)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Turbuhaler® M2 (1.5 mg terbutaline)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Turbuhaler® M3 (0.5 mg terbutaline)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Turbuhaler® M2 (0.5 mg terbutaline)
Number of subjects: 60
Study: 27420578

Group type: EXPERIMENTAL
Intervention: Ivabradine
Number of subjects: 97

Group type: COMPARATOR
Intervention: Metoprolol
Number of subjects: 97
Study: 24698298

Group type: EXPERIMENTAL
Intervention: Local anesthesia (group A, n=61)
Number of subjects: 249

Group type: COMPARATOR
Intervention: No local anesthesia (group B, n=92)
Number of subjects: 249

Group type: COMPARATOR
Intervention: No local anesthesia (group C, n=96)
Number of subjects: 249
Study: 22490873

Group type: EXPERIMENTAL
Intervention: Poor mental health (mental health index score ≤60)
Number of subjects: 0
Study: 20216468

Group type: EXPERIMENTAL
Intervention: Sodium cromoglycate (40 mg)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 18179313

Group type: EXPERIMENTAL
Intervention: d-amphetamine (20 mg)
Number of subjects: 40

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 40
Study: 16330394

Group type: EXPERIMENTAL
Intervention: Ethanol (0.97+/‐0.12 g/kg body weight)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Juice (placebo)
Number of subjects: 10
Study: 12192890

Group type: EXPERIMENTAL
Intervention: Transdermal glyceryl trinitrate
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 9811982

Group type: EXPERIMENTAL
Intervention: Posterior cruciate ligament retention (n = 11)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Posterior stabilizing articular surface (n = 9)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 20
Study: 7898521

Group type: COMPARATOR
Intervention: CHOP chemotherapy
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Autologous bone marrow transplantation
Number of subjects: 106
Study: 2716162

Group type: EXPERIMENTAL
Intervention: Sustained-release PPA hydrochloride 75 mg once per day
Number of subjects: 881

Group type: EXPERIMENTAL
Intervention: Immediate-release PPA hydrochloride 25 mg three times per day
Number of subjects: 881

Group type: COMPARATOR
Intervention: Placebo capsules three times per day
Number of subjects: 881
Study: 564503

Group type: EXPERIMENTAL
Intervention: Infant walker training, 2 hours per day starting at 300 days of age
Number of subjects: 12

Group type: COMPARATOR
Intervention: No special training (control group)
Number of subjects: 12
Study: 31721042

Group type: EXPERIMENTAL
Intervention: Simple stimuli with varying degrees of target-distractor similarity
Number of subjects: 0
Study: 30676827

Group type: COMPARATOR
Intervention: COD training without external load (COD-0)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: COD training with a 12.5% body-mass external load (COD-12.5)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: COD training with a 50% body-mass external load (COD-50)
Number of subjects: 54
Study: 28182127

Group type: EXPERIMENTAL
Intervention: Metoprolol (23.75 or 47.5 mg, qd PO, dose escalated with 23.75 mg each time until target heart rate [HR] <70 bpm was achieved)
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 154
Study: 26556275

Group type: EXPERIMENTAL
Intervention: Clindamycin, ciprofloxacin, amoxicillin, and minocycline
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study: 23799683

Group type: EXPERIMENTAL
Intervention: Self-administered web-based computer intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 0
Study: 21326107

Group type: EXPERIMENTAL
Intervention: Olprinone at 0.2 μg·kg(‐1)·min(‐1)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Olprinone at 0.4 μg·kg(‐1)·min(‐1)
Number of subjects: 3

Group type: COMPARATOR
Intervention: Control group (0 μg·kg(‐1)·min(‐1))
Number of subjects: 3
Study: 19057445

Group type: EXPERIMENTAL
Intervention: Intravenous hydrocortisone 5 mg/kg/day in four divided doses for 7 days
Number of subjects: 38

Group type: COMPARATOR
Intervention: Normal saline (similar amount in a similar manner) for 7 days
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 38
Study: 17721240

Group type: EXPERIMENTAL
Intervention: Bolus injection of propofol (2.5 mg/kg)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: 1-, 2-, or 3-min infusion of propofol (2.5 mg/kg)
Number of subjects: 61
Study: 11027910

Group type: EXPERIMENTAL
Intervention: Gabapentin (titrated from 1,200 mg/day to a maximum of 2,400 mg/day)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Amitriptyline (titrated from 30 mg/day to a maximum of 90 mg/day)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Gabapentin
Number of subjects: 25

Group type: COMPARATOR
Intervention: Amitriptyline
Number of subjects: 25
Study: 9410677

Group type: EXPERIMENTAL
Intervention: Intraoperative fluoroscopic cholangiography (IOC) attempted in 138 patients
Number of subjects: 275

Group type: COMPARATOR
Intervention: No intraoperative fluoroscopic cholangiography (IOC) in 137 patients
Number of subjects: 275

Group type: EXPERIMENTAL
Intervention: Intraoperative fluoroscopic cholangiography (IOC)
Number of subjects: 275
Study: 8450987

Group type: EXPERIMENTAL
Intervention: Immediate treatment with antiepileptic drugs (carbamazepine, phenytoin, phenobarbital, or sodium valproate)
Number of subjects: 397

Group type: COMPARATOR
Intervention: Delayed treatment with the same antiepileptic drugs
Number of subjects: 397
Study: 3708118

Group type: EXPERIMENTAL
Intervention: Propranolol 10 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Propranolol 40 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Propranolol 80 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Propranolol 160 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Propranolol (all doses)
Number of subjects: 12
Study: 31684857

Group type: EXPERIMENTAL
Intervention: Models based on pathway scores
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Models based on true pathway mappings
Number of subjects: 0

Group type: COMPARATOR
Intervention: Models based on randomised pathway mappings
Number of subjects: 0
Study: 28141545

Group type: EXPERIMENTAL
Intervention: Fish oil supplementation (1000 mg containing 180 mg EPA and 120 mg DHA)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Fish oil supplementation
Number of subjects: 150
Study: 24756976

Group type: EXPERIMENTAL
Intervention: Transoral incisionless fundoplication (TIF)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Proton pump inhibitors (PPI)
Number of subjects: 63
Study: 23103775

Group type: EXPERIMENTAL
Intervention: Propofol 1 mg kg(‐1) (Group P)
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: Fentanyl 1 µg kg(‐1) (Group F)
Number of subjects: 222

Group type: COMPARATOR
Intervention: Saline (Group S)
Number of subjects: 222
Study: 22145448

Group type: EXPERIMENTAL
Intervention: Recombinant human growth hormone (rhGH)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Enteral nutrition
Number of subjects: 8
Study: 19451819

Group type: EXPERIMENTAL
Intervention: Estrogen plus progesterone replacement therapy
Number of subjects: 16608

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16608
Study: 17457713

Group type: EXPERIMENTAL
Intervention: 3-in-1 femoral nerve block with 40 ml of ropivacaine 0.375% (Group R)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Morphine loading dose of 2 mg (Group S)
Number of subjects: 34
Study: 12637461

Group type: EXPERIMENTAL
Intervention: Tamoxifen plus aminoglutethimide (500 mg/d for the first 2 years)
Number of subjects: 2021

Group type: COMPARATOR
Intervention: Tamoxifen (40 mg/d for the first 2 years, then 20 mg/d for 3 years)
Number of subjects: 2021

Group type: EXPERIMENTAL
Intervention: Tamoxifen plus aminoglutethimide
Number of subjects: 2021

Group type: COMPARATOR
Intervention: Tamoxifen
Number of subjects: 2021
Study: 10925565

Group type: EXPERIMENTAL
Intervention: 5 x 10(‐4)% fentanyl (10‐20 mL) administered epidurally during early first-stage labor (Group A)
Number of subjects: 318

Group type: COMPARATOR
Intervention: No analgesic during the early first stage of labor (Group B)
Number of subjects: 318

Group type: COMPARATOR
Intervention: No analgesic during the entire labor course (Group C)
Number of subjects: 318
Study: 8898515

Group type: EXPERIMENTAL
Intervention: Lifestyle exercise packet (LEP)
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Structured exercise packet (SEP)
Number of subjects: 113

Group type: COMPARATOR
Intervention: Control packet
Number of subjects: 113
Study: 1381024

Group type: EXPERIMENTAL
Intervention: Atenolol 100 mg
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Betaxolol 20 mg
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 6387631

Group type: EXPERIMENTAL
Intervention: Benson's technique augmented with GSR biofeedback (biofeedback‐aided relaxation, BAR)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Benson's relaxation technique (BRT)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 78
Study: 30786187

Group type: EXPERIMENTAL
Intervention: Plazomicin (15 mg per kilogram of body weight once daily)
Number of subjects: 609

Group type: COMPARATOR
Intervention: Meropenem (1 g every 8 hours)
Number of subjects: 609
Study: 29112869

Group type: EXPERIMENTAL
Intervention: Playing a video game modeled from sensory foraging behavior
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 27504543

Group type: EXPERIMENTAL
Intervention: 20% trichloro‐acetic acid peel plus 5% topical magnesium ascorbyl phosphate
Number of subjects: 148

Group type: COMPARATOR
Intervention: 20% trichloro‐acetic acid peel alone
Number of subjects: 148
Study: 25250862

Group type: EXPERIMENTAL
Intervention: Transulnar intervention (TUI)
Number of subjects: 636

Group type: COMPARATOR
Intervention: Transradial intervention (TRI)
Number of subjects: 636
Study: 22789919

Group type: EXPERIMENTAL
Intervention: Educational intervention (5-minute informational video and counseling about cataract, surgery, and surgical cost)
Number of subjects: 434

Group type: COMPARATOR
Intervention: Control group (no educational intervention)
Number of subjects: 434

Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 434
Study: 19427744

Group type: EXPERIMENTAL
Intervention: Induction chemotherapy (cisplatin 50 mg/m², Days 1 and 8; paclitaxel 175 mg/m² Day 1, every 21 days) followed by concurrent CRT (accelerated-hyperfractionated regimen, 45 Gy, 2 x 1.5 Gy/d, cisplatin 50 mg/m², Days 64 and 71, vinorelbine 20 mg/m², Days 64 and 71)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Definitive radiotherapy (total dose 65 or 71 Gy, depending on the mean lung dose) with additional concurrent chemotherapy (cisplatin 40 mg/m², Day 85; vinorelbine 15 mg/m², Days 85 and 92)
Number of subjects: 28
Study: 17513184

Group type: EXPERIMENTAL
Intervention: Antenatal magnesium sulphate therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no antenatal magnesium sulphate therapy)
Number of subjects: 0
Study: 15627414

Group type: EXPERIMENTAL
Intervention: Motor and verbal estimates of incline and azimuth from memory (Experiment 1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Motor estimates of azimuth from memory under various conditions (Experiment 2)
Number of subjects: 0
Study: 12013115

Group type: EXPERIMENTAL
Intervention: Bipolar electrocautery scissors
Number of subjects: 40

Group type: COMPARATOR
Intervention: Unipolar energy scalpel
Number of subjects: 40
Study: 10450371

Group type: EXPERIMENTAL
Intervention: Heidelberg Retina Tomograph (HRT)
Number of subjects: 81
Study: 7786657

Group type: EXPERIMENTAL
Intervention: Felodipine 2.5-10 mg twice daily
Number of subjects: 252

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 252

Group type: EXPERIMENTAL
Intervention: Felodipine
Number of subjects: 252
Study: 1536276

Group type: EXPERIMENTAL
Intervention: Clomipramine
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Desipramine
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study: 6504944

Group type: EXPERIMENTAL
Intervention: Pentoxifylline ('Trental' 400) 400 mg (2 tablets)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 30451531

Group type: EXPERIMENTAL
Intervention: Light force (300 g) CHG
Number of subjects: 40

Group type: COMPARATOR
Intervention: Heavy force (500 g) CHG
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study: 30100129

Group type: EXPERIMENTAL
Intervention: Hot sand fomentation (HSF) added to yoga and sesame seed oil application
Number of subjects: 60

Group type: COMPARATOR
Intervention: Yoga and sesame seed oil application (Control)
Number of subjects: 60
Study: 26484518

Group type: EXPERIMENTAL
Intervention: Mental practice and physical practice gait protocol (N=10)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Physical practice (N=10)
Number of subjects: 20
Study: 23691836

Group type: EXPERIMENTAL
Intervention: Error-encouragement training
Number of subjects: 164

Group type: COMPARATOR
Intervention: Error-avoidance training
Number of subjects: 164

Group type: COMPARATOR
Intervention: Control training
Number of subjects: 164
Study: 21762789

Group type: EXPERIMENTAL
Intervention: Integrated Home‐based Intervention Package (improved stoves, kitchen sinks, hand washing promotion, solar drinking water disinfection)
Number of subjects: 534

Group type: COMPARATOR
Intervention: Psychomotor stimulation intervention (Control)
Number of subjects: 534
Study: 19336462

Group type: EXPERIMENTAL
Intervention: Amusic subjects
Number of subjects: 0

Group type: COMPARATOR
Intervention: Matched controls
Number of subjects: 0
Study: 16493167

Group type: EXPERIMENTAL
Intervention: Continuous femoral nerve block with ropivacaine and oral hydrocodone
Number of subjects: 90

Group type: COMPARATOR
Intervention: Intra-articular injection of bupivacaine/morphine and oral oxycodone
Number of subjects: 90
Study: 14595562

Group type: EXPERIMENTAL
Intervention: High-Intensity Training (HIT)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Low-Intensity Endurance Training (ET)
Number of subjects: 6
Study: 11787715

Group type: EXPERIMENTAL
Intervention: 3 visits during pregnancy and early postpartum
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: 6 visits during pregnancy and early postpartum
Number of subjects: 130

Group type: COMPARATOR
Intervention: No intervention (control)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Intervention (3 visits and 6 visits combined)
Number of subjects: 130
Study: 9072885

Group type: EXPERIMENTAL
Intervention: Oral iron supplementation (Actiferrin, 3 x 1 cps/d, 724.5 mg elemental Fe per week)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Intravenous iron supplementation (Ferrum-Lek, 1 vial per week, 100 mg elemental iron per week)
Number of subjects: 61
Study: 1306677

Group type: EXPERIMENTAL
Intervention: Stimu-gum device
Number of subjects: 64

Group type: COMPARATOR
Intervention: Oral-B 35 manual toothbrush
Number of subjects: 64
Study: 3866334

Group type: EXPERIMENTAL
Intervention: EMLA 5% cream
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Xylocaine 5% ointment
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo cream
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Dry EMLA emulsion in cellulose discs
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo discs
Number of subjects: 30
Study: 31106886

Group type: EXPERIMENTAL
Intervention: Surgical intervention (n=57)
Number of subjects: 115

Group type: COMPARATOR
Intervention: Physiotherapy (n=58)
Number of subjects: 115
Study: 30249900

Group type: EXPERIMENTAL
Intervention: HAI with 5‐FU followed by UFT/LV (Arm A)
Number of subjects: 44

Group type: COMPARATOR
Intervention: UFT/LV alone (Arm B)
Number of subjects: 44
Study: 26626617

Group type: EXPERIMENTAL
Intervention: Sunitinib
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Everolimus
Number of subjects: 68
Study: 25022705

Group type: EXPERIMENTAL
Intervention: Combination treatment of IPL-F and LF-QS-Nd:YAG laser
Number of subjects: 24

Group type: COMPARATOR
Intervention: IPL-F alone (control group)
Number of subjects: 24
Study: 22040598

Group type: EXPERIMENTAL
Intervention: Dietary patterns in mothers: 'Fruits and vegetables', 'High-energy snack and processed foods', 'High-fat foods', 'Cereals and sweet foods'
Number of subjects: 454

Group type: EXPERIMENTAL
Intervention: Dietary patterns in fathers: 'Fruits', 'High-energy snack and processed foods', 'High-fat foods', 'Potatoes and vegetables'
Number of subjects: 454

Group type: EXPERIMENTAL
Intervention: Correlation between dietary patterns of mothers and fathers
Number of subjects: 454
Study: 21438412

Group type: EXPERIMENTAL
Intervention: Naoxinduotai capsule + perindopril
Number of subjects: 62

Group type: COMPARATOR
Intervention: Perindopril
Number of subjects: 62
Study: 17564200

Group type: EXPERIMENTAL
Intervention: Body tilt at 135 degrees
Number of subjects: 0

Group type: COMPARATOR
Intervention: Body tilt at 0, 45, 90 degrees, and 180 degrees
Number of subjects: 0
Study: 16043156

Group type: EXPERIMENTAL
Intervention: Lumina intense pulsed light system
Number of subjects: 12
Study: 12107665

Group type: EXPERIMENTAL
Intervention: Risedronate 5 mg daily
Number of subjects: 640

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 640

Group type: EXPERIMENTAL
Intervention: Risedronate 5 mg daily (stratified by age 64 years)
Number of subjects: 640

Group type: EXPERIMENTAL
Intervention: Risedronate 5 mg daily (stratified by age 76 years)
Number of subjects: 640
Study: 10023618

Group type: EXPERIMENTAL
Intervention: Network Therapy (NT)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 30
Study: 7581086

Group type: EXPERIMENTAL
Intervention: FK506 (0.05 mg/kg i.v. or 0.15 mg/kg orally twice a day)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: FK506
Number of subjects: 49
Study: 1698845

Group type: EXPERIMENTAL
Intervention: Continuous antigen challenge
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Oral administration of 1 mg/kg methylprednisolone
Number of subjects: 20

Group type: COMPARATOR
Intervention: Codeine challenge
Number of subjects: 20

Group type: COMPARATOR
Intervention: Intermittent antigen challenge
Number of subjects: 20
Study: 417377

Group type: EXPERIMENTAL
Intervention: Intramuscular loxapine
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Oral loxapine
Number of subjects: 10
Study: 31738406

Group type: EXPERIMENTAL
Intervention: Regular home visits by a nurse
Number of subjects: 80
Study: 31743569

Group type: EXPERIMENTAL
Intervention: Ipragliflozin (50 mg, once daily)
Number of subjects: 161

Group type: COMPARATOR
Intervention: Placebo (initially) then switched to Ipragliflozin (50 mg, once daily)
Number of subjects: 161
Study: 28727771

Group type: EXPERIMENTAL
Intervention: Supervised high intensity exercise program
Number of subjects: 109

Group type: COMPARATOR
Intervention: Usual care control group
Number of subjects: 109
Study: 26124797

Group type: EXPERIMENTAL
Intervention: Aerobic exercise training and dietary measures
Number of subjects: 100

Group type: COMPARATOR
Intervention: No training intervention
Number of subjects: 100
Study: 22770818

Group type: EXPERIMENTAL
Intervention: Single sterile water injection (n=147)
Number of subjects: 305

Group type: COMPARATOR
Intervention: Four sterile water injections (n=158)
Number of subjects: 305
Study: 20680312

Group type: EXPERIMENTAL
Intervention: Continuous suturing technique
Number of subjects: 160

Group type: COMPARATOR
Intervention: Interrupted suturing technique
Number of subjects: 160
Study: 20396720

Group type: EXPERIMENTAL
Intervention: Combination of artrofoon and anaferon
Number of subjects: 0
Study: 17185130

Group type: COMPARATOR
Intervention: 5.25% NaOCl/15% EDTA
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: 1.3% NaOCl/BioPure MTAD
Number of subjects: 26